Table 4.

Association between HCC treatment delay and OS among patients who received HCC treatment

Characteristic	Univariate			Multivariable*
	HR	95% CI	P Value	HR	95% CI	P Value
Landmark at 120 days	1.04	1.00, 1.07	0.033	1.01	0.98, 1.05	0.522
Landmark at 150 days	1.04	1.01, 1.07	0.007	1.01	0.98, 1.04	0.399
Landmark at 180 days	1.05	1.02, 1.08	<0.001	1.03	1.00, 1.06	0.078

^*Adjusted by demographic, socioeconomic, center, regions, and clinical characteristic variables included in Table 3.